|Bid||95.04 x 800|
|Ask||112.00 x 800|
|Day's Range||96.69 - 99.80|
|52 Week Range||65.67 - 108.90|
|Beta (5Y Monthly)||0.85|
|PE Ratio (TTM)||18.47|
|Earnings Date||Feb 03, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||112.79|
Subscribe to Yahoo Finance Plus to view Fair Value for LITELearn more
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
Lumentum (LITE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Lumentum Holdings Inc. (NASDAQ: LITE) ("Lumentum") and NeoPhotonics Corporation (NYSE: NPTN) ("NeoPhotonics") today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") with respect to Lumentum's pending transaction with NeoPhotonics. The expiration of the waiting period under the HSR Act satisfies one of the conditions to the closing of the transaction contemplated by the previously announced Agreement and Plan of Merger (